Patents by Inventor Arndt Hartmann

Arndt Hartmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING RCC SUBTYPES
    Publication number: 20220098677
    Abstract: The present invention relates to a method for determining in a subject's biological sample the relative proportions of papillary renal cell carcinoma (pRCC), clear cell renal cell carcinoma (ccRCC), and chromophobe renal cell carcinoma (chRCC), an array comprising capture molecules capable of specifically binding to RCC signature genes or coding sequences thereof or products encoded thereby, and the use of RCC signature genes for classifying a subject into a renal cell carcinoma (RCC) risk group and/or for determining in a subject's biological sample the relative proportions of pRCC, ccRCC, and chRCC.
    Type: Application
    Filed: October 7, 2021
    Publication date: March 31, 2022
    Applicants: Robert Bosch Gesellschaft für medizinische Forschung mbH, Eberhard Karls Universität Tuebingen Medizinische Fakultaet, Friedrich-Alexander-Universitaet Erlangen-Nuernberg
    Inventors: Florian Buettner, Elke Schaeffeler, Matthias Schwab, Stefan Winter, Jens Bedke, Arnulf Stenzl, Arndt Hartmann